Inhibition of Prostate Cancer-Cell Proliferation by Essiac
In-vitro evidence supports the view that when Essiac is present there is a decrease in the growth of both the cancerous prostate cells and the noncancerous transformed cells. It was concluded that people who have a weak immune system or immune-suppressed individuals may benefit from the proper dosage of Essiac in order to inhibit the growth of cancerous cells.
Published:
Journal of Alternative and Complementary Medicine, Volume 10, Number 4, 2004, pp. 687-691 ©Mary Ann Liebert, Inc.
Attribution:
Jessica Ottenweller, Karson Putt, Elliott J. Blumenthal, Ph.D., Shree Dhawale, Ph.D., of the Department of Biology, Indiana University-Purdue University Fort Wayne, For Wayne, IN and S.W Dhawale, Ph.D. of the Department of Chemistry, Indiana University, Richmond Campus, Richmond, IN